SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-18-189435
Filing Date
2018-06-11
Accepted
2018-06-11 16:17:18
Documents
6
Effectiveness Date
2018-06-11

Document Format Files

Seq Description Document Type Size
1 S-8 d603403ds8.htm S-8 64519
2 EX-5.1 d603403dex51.htm EX-5.1 7345
3 EX-23.1 d603403dex231.htm EX-23.1 1608
4 EX-99.1 d603403dex991.htm EX-99.1 174475
5 EX-99.2 d603403dex992.htm EX-99.2 56263
6 GRAPHIC g603403g0607084625516.jpg GRAPHIC 2525
  Complete submission text file 0001193125-18-189435.txt   309002
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-225552 | Film No.: 18892178
SIC: 2836 Biological Products, (No Diagnostic Substances)